文献速递神经肿瘤

胶质瘤低频至高频异常神经磁活动的组织病理学与临床相关性

Histopathologic and Clinical Correlation of Aberrant Neuromagnetic Activities with Low to High Frequency of Gliomas.
PubMed 文献 · World Neurosurg · 2018-12-08

研究纳入25例胶质瘤患者与20名健康对照,用脑磁图(MEG)分析6个频段(1-4 Hz、4-8 Hz、8-12 Hz、12-30 Hz、30-45 Hz、55-75 Hz)的异常脑活动,并与组织病理学分级做相关分析。结果显示患者4-8 Hz、8-12 Hz和55-75 Hz脑活动明显改变,高级别与低级别胶质瘤在4-8 Hz和55-75 Hz的磁源功率显著不同,且4-8 Hz和55-75 Hz源功率幅度与胶质瘤分级明显相关。作者认为神经磁源异常程度是胶质瘤分级无创评估的潜在生物标志物,MEG未来可能在临床活检和手术规划中发挥作用。

要点

  • 25例胶质瘤患者与20名健康对照的MEG数据按6个频段分析并与组织病理学分级相关。
  • 患者4-8 Hz、8-12 Hz和55-75 Hz脑活动较对照明显改变。
  • 4-8 Hz和55-75 Hz磁源功率在高级别与低级别胶质瘤间显著不同,且与分级明显相关。

核心结论

  • 神经磁源异常程度是胶质瘤分级无创评估的潜在生物标志物。
  • MEG可无创、术前进行,未来可能在脑胶质瘤患者的临床活检和手术规划中发挥重要作用。

研究设计与样本

  • 研究纳入25例胶质瘤患者和20名健康对照,用脑磁图(MEG)系统采集数据。
  • MEG数据按1-4 Hz、4-8 Hz、8-12 Hz、12-30 Hz、30-45 Hz和55-75 Hz共6个频段分析。
  • 由神经病理学评估胶质瘤分级的神经磁特征,并与组织病理学及临床做相关分析。

主要发现

  • 与对照相比,胶质瘤患者在4-8 Hz、8-12 Hz和55-75 Hz的脑活动明显改变。
  • 高级别胶质瘤患者4-8 Hz和55-75 Hz脑活动的磁源功率与低级别胶质瘤患者显著不同。
  • 4-8 Hz和55-75 Hz脑活动的源功率幅度与胶质瘤组织病理学分级明显相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the low- to high-frequency range of abnormal brain activities and assess the histopathologic and clinical correlation in patients with glioma. METHODS: Twenty-five patients with glioma and 20 healthy controls were examined with a magnetoencephalography (MEG) system. MEG data collected in 6 frequency bands, including 1-4 Hz, 4-8 Hz, 8-12 Hz, 12-30 Hz, 30-45 Hz, and 55-75 Hz, were analyzed by neuropathology to assess neuromagnetic signatures of glioma grade. RESULTS: Compared with controls, patients with glioma showed greatly altered brain activities in 4-8 Hz, 8-12 Hz, and 55-75 Hz. Magnetic source power of brain activities in 4-8 Hz and 55-75 Hz in patients with high-grade gliomas significantly differed from that in patients with low-grade gliomas. The magnitude of source power of brain activities in 4-8 Hz and 55-75 Hz had marked correlation with the grading of gliomas in histopathological analyses. CONCLUSIONS: The degree of neuromagnetic source abnormality is a potential biomarker for noninvasive assessment of glioma grade. Because MEG tests can be performed noninvasively and preoperatively, MEG may play an important role in clinical biopsies and surgical planning for patients with brain gliomas in the future.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang K, Chen J, Xiang J, et al. Histopathologic and Clinical Correlation of Aberrant Neuromagnetic Activities with Low to High Frequency of Gliomas. World Neurosurg. 2018. PMID: 30529596. doi:10.1016/j.wneu.2018.11.235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。